Sunburst Financial Group LLC Acquires 39 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Sunburst Financial Group LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 2,022 shares of the healthcare conglomerate’s stock after purchasing an additional 39 shares during the quarter. Sunburst Financial Group LLC’s holdings in UnitedHealth Group were worth $1,023,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of UNH. Aljian Capital Management LLC raised its stake in shares of UnitedHealth Group by 11.7% in the 4th quarter. Aljian Capital Management LLC now owns 18,138 shares of the healthcare conglomerate’s stock valued at $9,176,000 after purchasing an additional 1,895 shares during the period. Intelligence Driven Advisers LLC raised its position in UnitedHealth Group by 9.7% in the 4th quarter. Intelligence Driven Advisers LLC now owns 496 shares of the healthcare conglomerate’s stock valued at $251,000 after buying an additional 44 shares during the last quarter. Avestar Capital LLC boosted its position in UnitedHealth Group by 7.6% during the 4th quarter. Avestar Capital LLC now owns 7,304 shares of the healthcare conglomerate’s stock worth $3,695,000 after acquiring an additional 518 shares during the last quarter. Hemington Wealth Management raised its holdings in shares of UnitedHealth Group by 5.9% in the fourth quarter. Hemington Wealth Management now owns 1,126 shares of the healthcare conglomerate’s stock valued at $569,000 after purchasing an additional 63 shares during the last quarter. Finally, Ingalls & Snyder LLC boosted its holdings in UnitedHealth Group by 1.7% during the fourth quarter. Ingalls & Snyder LLC now owns 8,670 shares of the healthcare conglomerate’s stock worth $4,386,000 after purchasing an additional 143 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $531.31 on Friday. The firm’s 50-day simple moving average is $524.58 and its 200 day simple moving average is $563.71. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a market cap of $488.95 billion, a price-to-earnings ratio of 34.28, a P/E/G ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the company posted $5.83 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. 0.33% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent research reports. Stephens increased their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Wells Fargo & Company cut their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Finally, KeyCorp restated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.